Fluticasone Furoate EP Impurity H is chemically (6S,8S,9R,10S,11S,13S,14S,16R,17R)-6-Chloro-9-fluoro-17-(((fluoromethyl)thio)carbonyl)-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl furan-2-carboxylate. Fluticasone Furoate EP Impurity H is supplied with detailed characterization data compliant with regulatory guideline. Fluticasone Furoate EP Impurity H can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Fluticasone.
關鍵字： 醫(yī)藥對照品;
祥根生物醫(yī)藥于2008年12月成立，是一家集藥物研發(fā)、生產(chǎn)、銷售的創(chuàng)新型醫(yī)藥高科技企業(yè)，榮獲“國家高新技術企業(yè)”和“博士后實踐創(chuàng)新基地”等稱號。祥根生物醫(yī)藥擁有藥物成分標準物質、關鍵中間體、原料藥與藥品進出口全產(chǎn)業(yè)鏈平臺。祥根是眾多全球知名標準品（Aozeal/USP/EP/LGC/Bachem/TLC/TRC/SynZeal/意大利試劑等）和原料藥（INKE/Bachem/瑞迪/意迪那等）總代理和授權代理商，處于行業(yè)領先水平。
祥根生物醫(yī)藥擁有一個尊重人才、重視績效、持續(xù)創(chuàng)新的平臺。 研發(fā)團隊由多名海外高層次人才領銜，研發(fā)人員50余人；獲得相關發(fā)明專利30余項。祥根生物醫(yī)藥的企業(yè)責任是：回報員工、回報合作伙伴、回報社會；企業(yè)愿景是：提升藥品質量，保護人類健康。